Skip to main content
Figure 2 | European Journal of Medical Research

Figure 2

From: The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals

Figure 2

2a. Rates of virological response according to treatment group, as treated, missing = failure. EvR early virological response (at least 2 log decay of Hcv-RnA at week 12), ETR end of treatment response (negative Hcv-RnA at the end of treatment), SvR sustained virological response. 2b. Rates of virological response according to treatment group, intent-to-treat, missing = failure. EvR early virological response (at least 2 log decay of Hcv-RnA at week 12), ETR end of treatment response (negative Hcv-RnA at the end of treatment), SvR sustained virological response.

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us